“We have made excellent progress on our sales force reorganization and we are beginning to see positive returns from our investment in sales assets,” said CEO Dan Goldberger.
The company’s unaudited report showed:
1. Fourth quarter revenue is expected at $8.9 million to $9.1 million.
2. This is an 8 percent to 10 percent increase over the same period last year.
3. Total year 2014 revenue is expected at $35.2 million to $35.4 million.
4. Full year revenue increased 6 percent to 7 percent over the same period in 2013.
5. This is the fifth consecutive quarter the company reported significant year-over-year revenue growth, a new record for the company.
More articles on orthopedic devices:
Globus Medical, Medtronic, Mazor Robotics & more—10 key notes
Inside orthopedic, spine device companies—3 stock trends
Benvenue Medical names Rick Simmons VP of sales & marketing
